🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To evaluate the efficacy and safety of fesoterodine on overactive bladder s...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-11
Trial ID
NCT00546637
Treatments Being Tested
The purpose of this study is to evaluate the tolerability of Fesoterodine a...
Status
Completed
Location
Multiple Locations
Start Date
2014-12
Trial ID
NCT02327936
Treatments Being Tested
The purpose of this study is to assess the effects of fesoterodine at 4mg a...
Status
Completed
Location
Division of Geriatric Medicine, Clinical Sciences Building, University of Alberta Hosp
Start Date
2016-08
Trial ID
NCT02240459
Treatments Being Tested
This Phase 3B study is designed to test if a fesoterodine flexible dose reg...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-08
Trial ID
NCT00536484
Treatments Being Tested
The drug being studied, fesoterodine fumarate helps prevent the bladder nec...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-06
Trial ID
NCT00798434
Treatments Being Tested
The subjects who have symptoms of overactive bladder (many trips to the bat...
Status
Completed
Location
New York Hospital, Cornell University
Start Date
2010-01
Trial ID
NCT00605319
Treatments Being Tested
The purposes of this study are: 1. To provide evidence from a randomized c...
Status
Completed
Location
Multiple Locations
Start Date
2007-10
Trial ID
NCT00547378
Treatments Being Tested
To explore the effects of fesoterodine when used in a flexible dose manner...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-02
Trial ID
NCT00806494
Treatments Being Tested
The study is designed to evaluate elements of cognitive function in subject...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-07
Trial ID
NCT01161472
Treatments Being Tested
The purpose of this study is to evaluate the long term tolerability of Feso...
Status
Completed
Location
CHU de Québec-Université Laval
Start Date
2015-10
Trial ID
NCT02614482
Treatments Being Tested